April 25, 2024 07:38 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Centre moves Supreme Court seeking modification of 2012 verdict in 2G spectrum case | 'Robert Vadra Ab Ki Baar' posters in Amethi as suspense looms over Congress candidate | Sam Pitroda's comment on wealth distribution stirs row, Congress distances itself, Amit Shah says 'party exposed' | Renowned dancer and ex-professor at Chennai academy arrested on sexual harassment charges | 'Has anyone robbed your mangalsutra during Congress rule?' Priyanka Gandhi counters PM's charge
Narendra Modi to interact with Gennova Biopharma, Biological E and Dr. Reddy’s teams Narendra Modi
Narendra Modi Twitter page

Narendra Modi to interact with Gennova Biopharma, Biological E and Dr. Reddy’s teams

India Blooms News Service | @indiablooms | 29 Nov 2020, 08:11 pm

New Delhi: Prime Minister Narendra Modi will interact via video conferencing with Gennova Biopharma, Biological E and Dr. Reddy’s teams involved in developing a COVID-19 vaccine on Monday.

In a tweet, the Prime Minister said, "Tomorrow, on 30th November 2020, PM @narendramodi will interact, via video conferencing, with three teams that are involved in developing a COVID-19 vaccine. The teams he will interact with are from Gennova Biopharma, Biological E and Dr. Reddy’s."

Meanwhile, the Serum Institute will apply within two weeks for an emergency license to use the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the Indian vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.

"As of now, we don't have anything in writing with the government of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July 2021," he told reporters at a press conference.

"We are in the process of applying in the next two weeks for the emergency use," he added.

PM Modi on Saturday visited Zydus Biotech Park in Ahmedabad and Bharat Biotech facility in Hyderabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila as well as the vaccine candidate by Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.